Revvity Basic EPS 2010-2024 | RVTY
Revvity annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Revvity basic eps for the quarter ending September 30, 2024 was $0.77, a 862.5% increase year-over-year.
- Revvity basic eps for the twelve months ending September 30, 2024 was $2.12, a 63.95% decline year-over-year.
- Revvity annual basic eps for 2023 was $0.006B, a 23.28% increase from 2022.
- Revvity annual basic eps for 2022 was $0.005B, a 44.46% decline from 2021.
- Revvity annual basic eps for 2021 was $0.008B, a 24.54% increase from 2020.
| Revvity Annual Basic EPS | |
|---|---|
| 2023 | $5.56 |
| 2022 | $4.51 |
| 2021 | $8.12 |
| 2020 | $6.52 |
| 2019 | $2.06 |
| 2018 | $2.15 |
| 2017 | $2.67 |
| 2016 | $2.14 |
| 2015 | $1.89 |
| 2014 | $1.40 |
| 2013 | $1.49 |
| 2012 | $0.61 |
| 2011 | $0.07 |
| 2010 | $3.34 |
| 2009 | $0.71 |
| Revvity Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $0.77 |
| 2024-06-30 | $0.45 |
| 2024-03-31 | $0.21 |
| 2023-12-31 | $0.69 |
| 2023-09-30 | $0.08 |
| 2023-06-30 | $0.28 |
| 2023-03-31 | $4.51 |
| 2022-12-31 | $1.01 |
| 2022-09-30 | $0.68 |
| 2022-06-30 | $1.42 |
| 2022-03-31 | $1.40 |
| 2021-12-31 | $1.41 |
| 2021-09-30 | $1.12 |
| 2021-06-30 | $2.20 |
| 2021-03-31 | $3.39 |
| 2020-12-31 | $3.41 |
| 2020-09-30 | $1.58 |
| 2020-06-30 | $1.23 |
| 2020-03-31 | $0.30 |
| 2019-12-31 | $0.59 |
| 2019-09-30 | $0.53 |
| 2019-06-30 | $0.62 |
| 2019-03-31 | $0.32 |
| 2018-12-31 | $0.64 |
| 2018-09-30 | $0.69 |
| 2018-06-30 | $0.58 |
| 2018-03-31 | $0.24 |
| 2017-12-31 | $-0.37 |
| 2017-09-30 | $0.83 |
| 2017-06-30 | $1.86 |
| 2017-03-31 | $0.35 |
| 2016-12-31 | $0.59 |
| 2016-09-30 | $0.53 |
| 2016-06-30 | $0.59 |
| 2016-03-31 | $0.43 |
| 2015-12-31 | $0.61 |
| 2015-09-30 | $0.49 |
| 2015-06-30 | $0.43 |
| 2015-03-31 | $0.36 |
| 2014-12-31 | $0.27 |
| 2014-09-30 | $0.38 |
| 2014-06-30 | $0.45 |
| 2014-03-31 | $0.30 |
| 2013-12-31 | $0.60 |
| 2013-09-30 | $0.36 |
| 2013-06-30 | $0.25 |
| 2013-03-31 | $0.28 |
| 2012-12-31 | $-0.15 |
| 2012-09-30 | $0.26 |
| 2012-06-30 | $0.30 |
| 2012-03-31 | $0.20 |
| 2011-12-31 | $-0.73 |
| 2011-09-30 | $0.32 |
| 2011-06-30 | $0.26 |
| 2011-03-31 | $0.22 |
| 2010-12-31 | $2.53 |
| 2010-09-30 | $0.11 |
| 2010-06-30 | $0.49 |
| 2010-03-31 | $0.21 |
| 2009-12-31 | $0.31 |
| 2009-09-30 | $0.12 |
| 2009-06-30 | $0.19 |
| 2009-03-31 | $0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.634B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| Cencora (COR) | United States | $48.280B | 17.81 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |